ICU Medical, Inc. (NASDAQ:ICUI) shares hit a new 52-week high on Thursday . The stock traded as high as $181.58 and last traded at $181.60, with a volume of 17,075 shares trading hands. The stock had previously closed at $180.15.

Several brokerages have weighed in on ICUI. Gabelli reiterated a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. BidaskClub downgraded ICU Medical from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Zacks Investment Research downgraded ICU Medical from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 15th. Finally, Sidoti downgraded ICU Medical from a “buy” rating to a “neutral” rating in a report on Tuesday, June 20th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $193.00.

The stock’s 50 day moving average is $172.54 and its 200 day moving average is $163.75. The company has a market capitalization of $3.57 billion, a P/E ratio of 72.11 and a beta of 0.36.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.06). ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The company had revenue of $331.51 million during the quarter, compared to analysts’ expectations of $318.30 million. During the same quarter in the previous year, the company earned $1.15 EPS. The firm’s quarterly revenue was up 242.8% compared to the same quarter last year. Equities analysts predict that ICU Medical, Inc. will post $4.11 earnings per share for the current fiscal year.

In other ICU Medical news, VP Virginia Ruth Sanzone sold 1,784 shares of the stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $174.47, for a total value of $311,254.48. Following the completion of the sale, the vice president now owns 102 shares in the company, valued at approximately $17,795.94. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert S. Swinney sold 463 shares of the stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $181.25, for a total transaction of $83,918.75. Following the completion of the sale, the director now owns 14,330 shares of the company’s stock, valued at approximately $2,597,312.50. The disclosure for this sale can be found here. In the last quarter, insiders sold 213,012 shares of company stock valued at $36,438,659. Insiders own 15.90% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the business. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in ICU Medical by 10.3% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock worth $122,000 after buying an additional 66 shares in the last quarter. Riverhead Capital Management LLC lifted its position in ICU Medical by 99.8% in the 2nd quarter. Riverhead Capital Management LLC now owns 999 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 499 shares in the last quarter. Victory Capital Management Inc. lifted its position in ICU Medical by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 1,050 shares of the medical instruments supplier’s stock worth $181,000 after buying an additional 157 shares in the last quarter. Ameritas Investment Partners Inc. purchased a new stake in ICU Medical in the 1st quarter worth approximately $194,000. Finally, Parametrica Management Ltd purchased a new stake in ICU Medical in the 2nd quarter worth approximately $213,000. Institutional investors own 78.13% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/16/icu-medical-inc-icui-reaches-new-1-year-high-at-181-58.html.

ICU Medical Company Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Receive News & Stock Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related stocks with our FREE daily email newsletter.